“Aprepitant, a Novel Neurokinin-1 Receptor Antagonist in Management of Chemotherapy Induces Nausea Vomiting (CINV) in Cancer Patients”. International Journal of Research in Clinical and Hospital Pharmacy, vol. 2, no. 1, Sept. 2019, pp. 1-4, https://rubatosis.org/journals/index.php/ijrhcp/article/view/144.